Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting-Reference-Cited by-同舟云学术

Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting

Published:2015-11-20 Issue:2 Volume:99 Page:172-185
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Kalman LV¹,Agúndez JAG²,Appell M Lindqvist³,Black JL⁴,Bell GC⁵,Boukouvala S⁶,Bruckner C⁷,Bruford E⁸,Caudle K⁹,Coulthard SA¹⁰,Daly AK¹⁰,Tredici AL Del¹¹,den Dunnen JT¹²,Drozda K¹³,Everts RE¹⁴,Flockhart D¹⁵,Freimuth RR⁴,Gaedigk A¹⁶,Hachad H¹⁷,Hartshorne T¹⁸,Ingelman-Sundberg M¹⁹,Klein TE²⁰,Lauschke VM¹⁹,Maglott DR²¹,McLeod HL⁵,McMillin GA²²,Meyer UA²³,Müller DJ²⁴,Nickerson DA²⁵,Oetting WS²⁶,Pacanowski M¹³,Pratt VM¹⁵,Relling MV⁹,Roberts A²⁷,Rubinstein WS²¹,Sangkuhl K²⁰,Schwab M²⁸,Scott SA²⁹,Sim SC¹⁹,Thirumaran RK³⁰,Toji LH³¹,Tyndale RF³²,van Schaik RHN³³,Whirl-Carrillo M²⁰,Yeo KTJ³⁴,Zanger UM²⁸

Affiliation:

1. Centers for Disease Control and Prevention; Atlanta Georgia USA

2. Department of Pharmacology; University of Extremadura; Cáceres Spain

3. Division of Drug Research; Department of Medical and Health Sciences; Faculty of Medicine and Health Sciences, Linköping University; Linköping Sweden

4. Mayo Clinic; Rochester Minnesota USA

5. Moffitt Cancer Center; Tampa Florida USA

6. Department of Molecular Biology and Genetics; Democritus University of Thrace; Alexandroupolis Greece

7. Affymetrix; Santa Clara California USA

8. HUGO Gene Nomenclature Committee (HGNC), EMBL-EBI, European Molecular Biology Laboratory; Wellcome Genome Campus Hinxton UK

9. St. Jude Children's Research Hospital; Memphis Tennessee USA

10. Institute of Cellular Medicine, Newcastle University; Newcastle upon Tyne UK

11. Millennium Health, LLC; San Diego California USA

12. Department of Human Genetics and Clinical Genetics; Leiden University Medical Center; Leiden The Netherlands

13. US Food and Drug Administration; Silver Spring Maryland USA

14. Agena Bioscience; San Diego California USA

15. Indiana University School of Medicine; Indianapolis Indiana USA

16. Division of Clinical Pharmacology and Therapeutic Innovation; Children's Mercy Kansas City and School of Medicine, University of Missouri-Kansas City; Kansas City Missouri USA

17. Translational Software; Bellevue Washington USA

18. Department of Genetic Analysis; Thermo Fisher Scientific; South San Francisco California USA

19. Department of Physiology and Pharmacology; Karolinska Institutet; Stockholm Sweden

20. Department of Genetics; Stanford University; Stanford California USA

21. National Institutes of Health / National Library of Medicine / National Center for Biotechnology Information; Bethesda Maryland USA

22. University of Utah and ARUP Laboratories; Salt Lake City Utah USA

23. University of Basel; Basel Switzerland

24. Department of Psychiatry; University of Toronto, CAMH; Toronto Ontario Canada

25. Department of Genome Sciences; University of Washington; Seattle Washington USA

26. Department of Experimental and Clinical Pharmacology; University of Minnesota; Minneapolis Minnesota USA

27. Aegis Science Corporation; Nashville Tennessee USA

28. Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart and Department of Clinical Pharmacology, University Hospital; Tuebingen Germany

29. Department of Genetics and Genomic Sciences; Icahn School of Medicine at Mount Sinai; New York New York USA

30. Genelex Corporation; Seattle Washington USA

31. Coriell Institute for Medical Research; Camden New Jersey USA

32. CAMH and the Departments of Psychiatry and Pharmacology & Toxicology, University of Toronto; Toronto Ontario Canada

33. Department of Clinical Chemistry; Erasmus MC Rotterdam, International Federation for Clinical Chemistry (IFCC) Task Force Pharmacogenetics; Rotterdam The Netherlands

34. Department of Pathology; The University of Chicago; Chicago Illinois USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference73 articles.

1. Personalized pharmacogenomics: predicting efficacy and adverse drug reactions;Pirmohamed;Annu. Rev. Genomics Hum. Genet.,2014

2. Pharmacogenetics - five decades of therapeutic lessons from genetic diversity;Meyer;Nat. Rev. Genet.,2004

3. Is this the drug or dose for you? Impact and consideration of ethnic factors in global drug development, regulatory review, and clinical practice;Huang;Clin. Pharmacol. Ther.,2008

4. Inflammation-induced phenoconversion of polymorphic drug metabolizing enzymes: hypothesis with implications for personalized medicine;Shah;Drug Metab. Dispos.,2015

5. How personalized medicine became genetic, and racial: Werner Kalow and the formations of pharmacogenetics;Jones;J. Hist. Med. Allied Sci.,2013

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Arylamine N-Acetyltransferases;Reference Module in Biomedical Sciences;2024

2. Ontology anchored decision support tools: A focus on pharmacogenomics;Comprehensive Precision Medicine;2024

3. Challenges for the application of pharmacogenomics associated with the nomenclature of allelic variants;Pharmacogenomics;2023-10

4. ursaPGx: a new R package to annotate pharmacogenetic star alleles using phased whole genome sequencing data;2023-07-26

5. Meta-analysis of CYP2C19 and CYP2D6 metabolic activity on antidepressant response from 13 clinical studies using genotype imputation;2023-06-28